Skip to main content
Menu

IVISense Cat K 680 FAST Fluorescent Probe

IVISense™ Cat K 680 FAST is a NIR fluorescent probe for monitoring cathepsin K (Cat K) activity in vivo. Cat K, a lysosomal protease found in osteoclasts, chondrocytes, and synovial fibroblasts, plays a key role in bone resorption and collagen breakdown. Elevated Cat K levels - common in osteoporosis, breast cancer, and bone metastases - make it a valuable marker for studying bone remodeling and assessing Cat K inhibitors as potential therapies.

Feature Specification
Unit Size 1 vial (10 doses)
Specificity Cathepsin K

IVISense™ Cat K 680 FAST is a NIR fluorescent probe for monitoring cathepsin K (Cat K) activity in vivo. Cat K, a lysosomal protease found in osteoclasts, chondrocytes, and synovial fibroblasts, plays a key role in bone resorption and collagen breakdown. Elevated Cat K levels - common in osteoporosis, breast cancer, and bone metastases - make it a valuable marker for studying bone remodeling and assessing Cat K inhibitors as potential therapies.

Product variant
Wave Length: 680 nm
Part #:
NEV11000
List price
USD 696.53
Your online price:
For research use only. Not for use in diagnostic procedures.

Loading...

Overview

Cat K 680 FAST is a Cathepsin K (Cat K) activatable fluorescent agent that is optically silent upon injection and produces fluorescent signal after cleavage by disease related Cathepsin K. Cat K is highly expressed in osteoclasts, suggesting a specialized role in bone resorption.

Cat K is found extracellularly along the bone and cartilage and intracellularly in lysozomes of osteoclasts attached to the bone. In addition to expression by osteoclasts, Cat K is also expressed by a broad range of other cell types including ovarian cells, colonic tissue, alveolar and bronchial epithelial cells, synovial fibroblasts, breast cancer cells, macrophages.

Cat K 680 FAST fluorescent probe is a member of a family of activatable imaging agents comprising a novel architecture, termed F.A.S.T. (Fluorescent Activatable Sensor Technology), that confers an improved pharmacokinetic profile with earlier imaging time points. This architecture offers higher target specific signal with reduced background while also reducing the optimal imaging time after injection.

Specifications

Brand
IVISense
Fluorescent Agent Type
Enzyme activated
Imaging Modality
Fluorescence
Shipping Conditions
Shipped Ambient
Specificity
Cathepsin K
Storage Conditions
-30 to -16 °C
Therapeutic Area
Arthritis
Atherosclerosis
Cardiovascular
Oncology
Unit Size
1 vial (10 doses)
Wave Length
680 nm

Resources

Are you looking for resources, click on the resource type to explore further.

1-1 of 1 Resources
Guide Icon
Guide
IVISense fluorescent probe selector guide for oncology research

The goal of in vivo fluorescence molecular imaging is to enable non-invasive visualization and quantification of cellular and...

Scroll Icon

Revvity AI Assistant Beta